查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1671138

乳房病变局部存在化法的全球市场:市场规模·占有率·趋势，产业分析 (各类型·各地区)，未来预测 (2025年～2034年)

Breast Lesion Localization Methods Market Size, Share, Trends, Industry Analysis Report: By Type and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 最近的一项研究，全球乳房病变定位市场预计到 2034 年将达到 47.2306 亿美元。该研究报告对当前的市场动态提供了详细的见解，并对未来的市场成长进行了分析。

乳房病变定位市场受到多种因素的推动，例如乳癌盛行率的增加、影像技术的进步以及对微创手术的需求不断增加。人们对早期发现的认识不断提高以及手术结果的改善也促进了乳房病变定位市场的成长。一个关键趋势是转向更精确、更患者友善的技术，例如使用放射性种子或磁性示踪剂进行定位，以最大限度地减少不适并缩短恢復时间。

乳房病变定位的市场机会存在于新兴地区，特别是亚太地区和拉丁美洲，这些地区的医疗保健基础设施正在改善，对乳癌检测技术的需求也在不断增长。随着个人化治疗方法和创新技术的不断发展，并专注于提高精准度和患者护理，预计市场将实现稳步成长。

乳房病变定位市场：分析概述

根据类型，有线引导定位继续成为市场的主导部分，因为它因其已建立的可靠性和简单性而被广泛使用。在转变为微创治疗的背景下，放射性同位素定位由于其准确性和患者舒适度而正在经历最快的增长。

北美由于采用了先进的在地化技术和完善的医疗保健体係而占据全球市场主导地位。同时，随着医疗保健基础设施的改善、乳癌意识的不断提高以及先进诊断技术的不断采用，亚太地区的乳房病变定位市场正在快速成长。

该市场的主要参与者包括 Hologic、CR Bard（被 BD 收购）、MiMedx Group 和 Cook Medical，提供各种定位技术，包括导丝技术和放射性同位素技术。其他主要贡献者包括磁性种子定位专家 Endomag 和乳癌手术定位产品供应商 IZI Medical Products。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 乳房病变局部存在化法市场洞察

  • 市场概述
  • 乳房病变局部存在化法的市场动态
    • 促进因素和机会
      • 影像技术的进步
      • 转向微创手术
      • 扩大采用个人化和有针对性的治疗方法
    • 阻碍因素与课题
      • 治疗成本高
  • 大环境分析
  • 乳房病变局部存在化法市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球乳房病变局部存在化法市场:各类型

  • 主要的分析结果
  • 简介
  • 线诱导式位置特定
  • 放射性同位元素式位置特定
  • 磁描绘器
  • 其他

第6章 全球乳房病变局部存在化法市场:各地区

  • 主要的分析结果
  • 简介
    • 乳房病变局部存在化法市场评估:各地区 (2020～2034年)
  • 北美
    • 北美:各类型 (2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类型 (2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各类型 (2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各类型 (2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各类型 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第7章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第8章 企业简介

  • Hologic Inc.
  • C.R. Bard(acquired by BD)
  • MiMedx Group Inc.
  • Cook Medical
  • Endomag
  • IZI Medical Products
  • Thermo Fisher Scientific
  • GE Healthcare
  • Magee-Womens Hospital
  • Siemens Healthineers
  • Medtronic
  • Philips Healthcare
  • Fujifilm Corporation
  • Johnson & Johnson
  • Canon Medical Systems
Product Code: PM1337

The global breast lesion localization methods market size is expected to reach USD 4,723.06 million by 2034, according to a new study by Polaris Market Research. The report "Breast Lesion Localization Methods Market Size, Share, Trends, Industry Analysis Report: By Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer, and Others) and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The breast lesion localization methods market is driven by several factors, including the increasing prevalence of breast cancer, advancements in imaging technologies, and growing demand for minimally invasive procedures. The rising awareness of early detection and improved surgical outcomes also contribute to the breast lesion localization methods market growth. Key trends include the shift towards more precise, patient-friendly techniques such as radioactive seed and magnetic tracer localization, which minimize discomfort and reduce recovery times.

Breast lesion localization methods market opportunities exist in emerging regions, particularly in Asia Pacific and Latin America, where healthcare infrastructure is improving, and the demand for breast cancer detection technologies is rising. As personalized treatment approaches and innovative technologies continue to evolve, the market is expected to experience steady growth, with a focus on enhancing both accuracy and patient care.

Breast Lesion Localization Methods Market Report Highlights

Based on type, wire guided localization remains the dominant segment in the market, as it is widely used due to its established reliability and simplicity. The radioisotope localization segment is experiencing the fastest growth, driven by its precision and patient comfort, with an increasing shift towards minimally invasive procedures.

North America dominates the global market, with strong adoption of advanced localization technologies and well-established healthcare systems. Meanwhile, the Asia Pacific breast lesion localization methods market is witnessing rapid growth, supported by improving healthcare infrastructure, rising breast cancer awareness, and increasing adoption of advanced diagnostic methods.

A few of the key players in the market include Hologic Inc., C.R. Bard (acquired by BD), MiMedx Group Inc., and Cook Medical, which offer a range of localization technologies, such as wire-guided and radioisotope methods. Other significant contributors are Endomag, which specializes in magnetic seed localization, and IZI Medical Products, a supplier of localization products for breast cancer surgery.

Polaris Market Research has segmented the breast lesion localization methods market report on the basis of type and region:

By Type Outlook (Revenue-USD Million, 2020-2034)

  • Wire Guided Localization
  • Radioisotope Localization
  • Magnetic Tracer
  • Others

By Regional Outlook (Revenue-USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Breast Lesion Localization Methods Market Insights

  • 4.1. Breast Lesion Localization Methods Market - Market Snapshot
  • 4.2. Breast Lesion Localization Methods Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Imaging Technologies
      • 4.2.1.2. Shift Toward Minimally Invasive Procedures
      • 4.2.1.3. Rising Adoption of Personalized and Targeted Treatment Approaches
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of the Methods
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Breast Lesion Localization Methods Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Breast Lesion Localization Methods Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 5.3. Wire Guided Localization
    • 5.3.1. Global Breast Lesion Localization Methods Market, by Wire Guided Localization, by Region, 2020-2034 (USD Million)
  • 5.4. Radioisotope Localization
    • 5.4.1. Global Breast Lesion Localization Methods Market, by Radioisotope Localization, by Region, 2020-2034 (USD Million)
  • 5.5. Magnetic Tracer
    • 5.5.1. Global Breast Lesion Localization Methods Market, by Magnetic Tracer, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Breast Lesion Localization Methods Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Breast Lesion Localization Methods Market, by Geography

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Breast Lesion Localization Methods Market Assessment, by Geography, 2020-2034 (USD Million)
  • 6.3. Breast Lesion Localization Methods Market - North America
    • 6.3.1. North America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.3.2. Breast Lesion Localization Methods Market - US
      • 6.3.2.1. US: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.3.3. Breast Lesion Localization Methods Market - Canada
      • 6.3.3.1. Canada: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.4. Breast Lesion Localization Methods Market - Europe
    • 6.4.1. Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.2. Breast Lesion Localization Methods Market - UK
      • 6.4.2.1. UK: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.3. Breast Lesion Localization Methods Market - France
      • 6.4.3.1. France: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.4. Breast Lesion Localization Methods Market - Germany
      • 6.4.4.1. Germany: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.5. Breast Lesion Localization Methods Market - Italy
      • 6.4.5.1. Italy: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.6. Breast Lesion Localization Methods Market - Spain
      • 6.4.6.1. Spain: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.7. Breast Lesion Localization Methods Market - Netherlands
      • 6.4.7.1. Netherlands: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.8. Breast Lesion Localization Methods Market - Russia
      • 6.4.8.1. Russia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.4.9. Breast Lesion Localization Methods Market - Rest of Europe
      • 6.4.9.1. Rest of Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.5. Breast Lesion Localization Methods Market - Asia Pacific
    • 6.5.1. Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.2. Breast Lesion Localization Methods Market - China
      • 6.5.2.1. China: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.3. Breast Lesion Localization Methods Market - India
      • 6.5.3.1. India: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.4. Breast Lesion Localization Methods Market - Malaysia
      • 6.5.4.1. Malaysia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.5. Breast Lesion Localization Methods Market - Japan
      • 6.5.5.1. Japan: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.6. Breast Lesion Localization Methods Market - Indonesia
      • 6.5.6.1. Indonesia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.7. Breast Lesion Localization Methods Market - South Korea
      • 6.5.7.1. South Korea: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.8. Breast Lesion Localization Methods Market - Australia
      • 6.5.8.1. Australia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.5.9. Breast Lesion Localization Methods Market - Rest of Asia Pacific
      • 6.5.9.1. Rest of Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.6. Breast Lesion Localization Methods Market - Middle East & Africa
    • 6.6.1. Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.2. Breast Lesion Localization Methods Market - Saudi Arabia
      • 6.6.2.1. Saudi Arabia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.3. Breast Lesion Localization Methods Market - UAE
      • 6.6.3.1. UAE: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.4. Breast Lesion Localization Methods Market - Israel
      • 6.6.4.1. Israel: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.5. Breast Lesion Localization Methods Market - South Africa
      • 6.6.5.1. South Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.6.6. Breast Lesion Localization Methods Market - Rest of Middle East & Africa
      • 6.6.6.1. Rest of Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • 6.7. Breast Lesion Localization Methods Market - Latin America
    • 6.7.1. Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.2. Breast Lesion Localization Methods Market - Mexico
      • 6.7.2.1. Mexico: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.3. Breast Lesion Localization Methods Market - Brazil
      • 6.7.3.1. Brazil: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.4. Breast Lesion Localization Methods Market - Argentina
      • 6.7.4.1. Argentina: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
    • 6.7.5. Breast Lesion Localization Methods Market - Rest of Latin America
      • 6.7.5.1. Rest of Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)

7. Competitive Landscape

  • 7.1. Expansion and Acquisition Analysis
    • 7.1.1. Expansion
    • 7.1.2. Acquisitions
  • 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

  • 8.1. Hologic Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Development
  • 8.2. C.R. Bard (acquired by BD)
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Development
  • 8.3. MiMedx Group Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Development
  • 8.4. Cook Medical
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Development
  • 8.5. Endomag
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Development
  • 8.6. IZI Medical Products
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Development
  • 8.7. Thermo Fisher Scientific
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Development
  • 8.8. GE Healthcare
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Development
  • 8.9. Magee-Womens Hospital
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Development
  • 8.10. Siemens Healthineers
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Development
  • 8.11. Medtronic
    • 8.11.1. Company Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Recent Development
  • 8.12. Philips Healthcare
    • 8.12.1. Company Overview
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Recent Development
  • 8.13. Fujifilm Corporation
    • 8.13.1. Company Overview
    • 8.13.2. Financial Performance
    • 8.13.3. Product Benchmarking
    • 8.13.4. Recent Development
  • 8.14. Johnson & Johnson
    • 8.14.1. Company Overview
    • 8.14.2. Financial Performance
    • 8.14.3. Product Benchmarking
    • 8.14.4. Recent Development
  • 8.15. Canon Medical Systems
    • 8.15.1. Company Overview
    • 8.15.2. Financial Performance
    • 8.15.3. Product Benchmarking
    • 8.15.4. Recent Development

List of Tables:

  • Table 1 Global Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 2 North America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 3 US: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 4 Canada: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 5 Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 6 UK: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 7 France: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 8 Germany: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 9 Italy: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 10 Spain: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 11 Netherlands: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 12 Russia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 13 Rest of Europe: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 14 Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 15 China: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 16 India: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 17 Malaysia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 18 Japan: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 19 Indonesia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 20 South Korea: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 21 Australia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 22 Rest of Asia Pacific: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 23 Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 24 Saudi Arabia: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 25 UAE: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 26 Israel: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 27 South Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 28 Rest of Middle East & Africa: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 29 Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 30 Mexico: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 31 Brazil: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 32 Argentina: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)
  • Table 33 Rest of Latin America: Breast Lesion Localization Methods Market, by Type, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Breast Lesion Localization Methods Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Breast Lesion Localization Methods Market, by Type, 2024 & 2034 (USD Million)